Off-Label Use of Cancer Drugs: A Benchmark Is Established

被引：14
|
作者：
Krzyzanowska, Monika K. [1 ,2 ,3 ]
机构：
[1] Princess Margaret Hosp, Toronto, ON, Canada
[2] Inst Clin Evaluat Sci, Toronto, ON, Canada
[3] Univ Toronto, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 09期
关键词：
BEVACIZUMAB; THERAPY; SAFETY;
D O I：
10.1200/JCO.2012.46.9460
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1125 / 1127
页数：3
相关论文
共 50 条
  • [31] Off-Label Use and the Spectre of Drug-Eluting Stent Thrombosis
    Cook, Stephane
    Wenaweser, Peter
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (04) : 273 - 276
  • [32] Use of off-label nephrology-related drugs in hospitalized pediatric patients: a retrospective study
    Yasinta, Marchella
    Che, Ruo-Chen
    Hu, Cai-Yu
    Du, Xiang-Hui
    Ding, Gui-Xia
    Huang, Song-Ming
    Chen, Ying
    Zhang, Ai-Hua
    WORLD JOURNAL OF PEDIATRICS, 2016, 12 (02) : 236 - 242
  • [33] Available evidence and outcome of off-label use of rituximab in clinical practice
    Danes, I.
    Agusti, A.
    Vallano, A.
    Martinez, J.
    Alerany, C.
    Ferrer, A.
    Lopez, A.
    Cortes-Hernandez, J.
    Bosch, J. A.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (09) : 1689 - 1699
  • [34] French national cohort of first use of dalbavancin: A high proportion of off-label use
    Dinh, Aurelien
    Duran, Clara
    Pavese, Patricia
    Khatchatourian, Lydie
    Monnin, Boris
    Bleibtreu, Alexandre
    Denis, Eric
    Etienne, Cedric
    Rouanes, Nicolas
    Mahieu, Rafael
    Bouchand, Frederique
    Davido, Benjamin
    Lotte, Romain
    Cabaret, Philippe
    Camou, Fabrice
    Chavanet, Pascal
    Assi, Assi
    Limonta, Silvia
    Lechiche, Catherine
    Riou, Raphaelle
    Courjon, Johan
    Illes, Gabriela
    Lacassin-Beller, Flore
    Senneville, Eric
    Adjodah, Chandra
    Baclet, Nicolas
    Bouchard, Odile
    Boutoille, David
    Brunin, Guillaume
    Carbognani, Daniel
    Delobel, Pierre
    Ferrand, Helene
    Imbert, Yves
    Leautez-Nainville, Sophie
    Le Moing, Vincent
    Loutfi, Bouchra
    Mrozek, Natacha
    Rouzic, Nicolas
    Talarmin, Jean-Philippe
    Tattevin, Pierre
    Weyrich, Pierre
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 54 (05) : 668 - 672
  • [35] Recommendations on off-label use of intravenous azithromycin in children
    Zhou, Pengxiang
    Wang, Xiaoling
    Zhang, Xianglin
    Xu, Baoping
    Tong, Xiaomei
    Zhou, Wei
    Shen, Kunling
    Zhai, Suodi
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (07)
  • [36] Off-Label Use of Recombinant Human Factor VIIa
    Goodnough, Lawrence Tim
    Levy, Jerrold H.
    ANNALS OF THORACIC SURGERY, 2014, 98 (02) : 393 - 395
  • [37] Pediatric Off-label Use of Recombinant Factor VIIa
    Alten, Jeffrey A.
    Benner, Kim
    Green, Kelsey
    Toole, Benjamin
    Tofil, Nancy M.
    Winkler, Margaret K.
    PEDIATRICS, 2009, 123 (03) : 1066 - 1072
  • [38] Off-Label Use of Topical Minoxidil in Alopecia: A Review
    Stoehr, Jenna R.
    Choi, Jennifer N.
    Colavincenzo, Maria
    Vanderweil, Stefan
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2019, 20 (02) : 237 - 250
  • [39] Off-label and unlicensed drug use in children population
    Moulis, Florence
    Durrieu, Genevieve
    Lapeyre-Mestre, Maryse
    THERAPIE, 2018, 73 (02): : 135 - 149
  • [40] Off-label use of intravitreal bevacizumab: A global conundrum
    Singh, Samya
    Saxena, Sandeep
    Akduman, Levent
    Meyer, Carsten H.
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2024, 72 (05) : 617 - 619
12345